Status:
WITHDRAWN
Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
Lead Sponsor:
Dennis Charney
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
21-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to test a candidate drug, Org 24448,in a phase II clinical trial in adult patients with moderately treatment-resistant unipolar major depressive disorder.
Detailed Description
Major depressive disorder (MDD) is a common, severe, chronic and often life-threatening illness. Major depression contributes to significant morbidity and mortality. Available pharmacotherapies for ma...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of MDD
- Have not responded to an adequate trial of one antidepressant in the current episode or have not completed antidepressant trials due to intolerance to ≤3 antidepressant medications in the current or a previous episode
Exclusion
- Presence of psychotic features, OCD, drug or alcohol dependency with the preceding 3 months
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00262665
Start Date
March 1 2005
End Date
March 1 2005
Last Update
December 11 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.